ACTA2 gene mutation causes childhood-onset stroke disorder via smooth muscle cell dysfunction leading to blocked arteries
Picture a rowdy bunch of young men and women crowding the pavement. They flit across the street and their number grows, blocking traffic with their immature antics. These are the smooth muscle cells, resulting from a gene mutation, that clog arteries and cause childhood-onset strokes similar to moyamoya disease. Researchers have found that these smooth muscle cells fail to fully mature, remaining developmentally flexible with a tendency to migrate beyond where they should be. Following injury to the carotid artery, mice with the mutation experience artery blockages (pictured, bottom left, with muscle in red combining with green inflammation markers to appear pink), neurological issues, and early death compared to normal mice (top). Treating the mutant mice with nicotinamide riboside, which alters cellular metabolism, boosted maturation of the immature cells and reduced their migration, restricting the impact of injury (right) and pointing to a new approach for treatment.
Written by
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.